Lorenzo Falchi, Marcel Nijland, Huiqiang Huang, Kim Linton, John Seymour, Rong Tao, Michal Kwiatek, Abel Costa, Theodoros Vassilakopoulos, Richard Greil, Ana Jiménez Ubieto, Shane Gangatharan, Ohad Benjamini, Catherine Thieblemont, Alessandra Tucci, Anna Elinder-Camburn, Arpad Illes, Jan Novak, Miguel Pavlovsky, Andrew McDonald, Dok Hyun Yoon, Yuko Mishima, Gauri Sunkersett, Jian Mei, Nabanita Mukherjee, Feng Zhu, Elena Favaro, Franck Morschhauser. "primary Phase 3 results from the epcore FL-1 trial of epcoritamab with rituximab and lenalidomide (R2) versus R2 for relapsed or refractory follicular lymphoma." Blood, 2025. doi:10.1182/blood-2025-466